It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 | Hyderabad, Telangana, India | ActiveBiodoz Therapeutics Private Limited, a active private limited company, was established on 27 December 2012 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U52390TG2012PTC085063. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Padmaja Bundla (Director), Venkat Kamalakar Bundla (Director). Past directors included Ramalakshmi Bulusu, Bhanu Teja Bulusu. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No.401,Millennium Square,Near Bio Diversity Park Gachibowli, Hyderabad, Telangana, 500037.
U52390TG2012PTC085063
085063
27 December 2012
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Biodoz Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Padmaja Bundla | Director | 27 Dec 2012 | Current |
| Venkat Kamalakar Bundla | Director | 27 Dec 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Nov 2024 | Past |
| Pramod Abcsdd | Director | 01 Nov 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biodoz Therapeutics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.9% decrease. The company also saw a substantial improvement in profitability, with a 85.28% increase in profit. The company's net worth dipped by a decrease of 4.31%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Biodoz Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Biodoz Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biodoz Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biodoz Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Biodoz Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Biodoz Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Progress on Padmaja Bundla was appointed as a Director was appointed as a Director on 27 Dec 2012 & has been associated with this company since 12 years 11 months . was documented.
The activity Venkat Kamalakar Bundla was appointed as a Director was appointed as a Director on 27 Dec 2012 & has been associated with this company since 12 years 11 months . was completed.
The activity Biodoz Therapeutics Private Limited was registered on 27 Dec 2012 with Roc Hyderabad & aged 12 years 11 months as per MCA records. was completed.
The CIN of Biodoz Therapeutics Private Limited is U52390TG2012PTC085063.
Biodoz Therapeutics Private Limited is headquartered at H.No.401,Millennium Square,Near Bio Diversity Park Gachibowli, Hyderabad, Telangana, 500037.
Biodoz Therapeutics Private Limited was incorporated on 27 December 2012.
The current directors of Biodoz Therapeutics Private Limited are
The primary industry of Biodoz Therapeutics Private Limited is Hospital And Medical Care.
Biodoz Therapeutics Private Limited is unlisted.
The authorized capital of Biodoz Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Biodoz Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX